Genfit
50 views | +0 today
Your new post is loading...
Your new post is loading...
Scooped by leportos
Scoop.it!

Liver Fibrosis Progression in HCV Infection

Liver Fibrosis Progression in HCV Infection | Genfit | Scoop.it
Research from JAMA Internal Medicine — Liver Fibrosis Progression in Hepatitis C Virus Infection After Seroconversion
more...
No comment yet.
Scooped by leportos
Scoop.it!

iBio Provides Updates on Its IBIO-CFB03 Fibrosis Drug Candidate and Other ... - Marketwired (press release)

iBio Provides Updates on Its IBIO-CFB03 Fibrosis Drug Candidate and Other ... - Marketwired (press release) | Genfit | Scoop.it
NEWARK, DE--(Marketwired - Dec 10, 2014) - iBio, Inc.
more...
No comment yet.
Scooped by leportos
Scoop.it!

Dual PPAR Agonists

Robert Henry, MD, from the University of California, San Diego discusses dual PPAR agonists and their potential for the treatment of type 2 diabetes and its ...
more...
No comment yet.
Scooped by leportos
Scoop.it!

Peroxisome Proliferator-Activated Receptors PPARs Treatment & Prevention Of Diseases

Peroxisome Proliferator-Activated Receptors (PPARs) As Molecular Targets For The Treatment And Prevention Of Diseases Air date: Wednesday, March 11, 2009, 3:...
more...
No comment yet.
Scooped by leportos
Scoop.it!

Current URL: http://health.clevelandclinic.org/2014/12/newly-fda-approved ... - Health Hub from Cleveland Clinic

Current URL: http://health.clevelandclinic.org/2014/12/newly-fda-approved ... - Health Hub from Cleveland Clinic | Genfit | Scoop.it
Those who suffer from idiopathic pulmonary fibrosis (IPF) may be breathing a little easier. In October 2014, the Food and Drug Administration approved two new d
more...
No comment yet.
Rescooped by leportos from Pharma Biotech Industry Review (Krishan Maggon)
Scoop.it!

Internet of Everything: Technologies & Minds (How the future is happening now) | Internet Of Things

Internet of Everything: Technologies & Minds  (How the future is happening now) | Internet Of Things | Genfit | Scoop.it
The Internet of Everything (IoE) represents the next “world-changing” revolution, after the Industrial Revolution of 1750 – 1900, and following the Computer & Internet revolution which started in the 1950’s. It is an exciting scenario in which objects, personal devices, even animals communicate, take Intelligent decisions, and autonomous actions on their own without human interaction. This revolution will completely transform industrial sectors and the entire world, for all of us, in ways as powerful as the Industrial Revolution and even more. It is our future, and it is happening now.

How is it happening? For an Evolution of Technologies, and with a Revolution of Minds…

 

Learn more:

 

http://www.scoop.it/t/securite-pc-et-internet/?tag=smart-TV

 

http://www.scoop.it/t/21st-century-learning-and-teaching/?tag=Internet+of+Things

 

http://www.scoop.it/t/securite-pc-et-internet/?tag=Internet+of+things

 

http://globaleducationandsocialmedia.wordpress.com/2014/01/21/why-is-it-a-must-to-have-basics-knowledge-of-cyber-security-in-a-connected-technology-world/

 


Via Gust MEES, Krishan Maggon
more...
Krishan Maggon 's curator insight, March 8, 2015 12:43 AM

CapGemini report about the impact of current and near future technology. 

Ian Berry's curator insight, March 9, 2015 2:07 AM

The last question interested me "One final question arises: what roles will we (humans) have in the “Internet of Everything” future?"


For me I'm more interested in What role does IoE play in what it means to be the remarkable, one-of-a-kind human being that each of us is?

Milton Jon's curator insight, March 18, 2015 5:48 AM

UW Health Information Management & Technology,. (2015). 6 Health Information Technology Infographics You Need To See Right Now - UW Health Information Management & Technology. Retrieved 18 March 2015

 

Fabio, reports on the ever-changing ways of how the internet has shaped our world today.

Scooped by leportos
Scoop.it!

Cystic Fibrosis Foundation Sells Drug's Rights for $3.3 Billion - Wall Street Journal

Cystic Fibrosis Foundation Sells Drug's Rights for $3.3 Billion
Wall Street Journal
The Cystic Fibrosis Foundation said Wednesday that it would receive $3.3 billion for the sale of royalty rights to drugs developed with its financial support.
more...
No comment yet.
Scooped by leportos
Scoop.it!

What is the status of PPAR-alpha agonists as targets for type 2 diabetes and cardiovascular disease?

Video by Bart Staels, PhD Department of Atherosclerosis, Institut Pasteur de Lille, UMR545 Inserm, University of Lille 2, Lille, France Produced by the Inter...
more...
No comment yet.
Scooped by leportos
Scoop.it!

GENFIT: GFT505 Eliminates NASH and Fibrosis in a Clinically Relevant Disease ... - Business Wire (press release)

GENFIT: GFT505 Eliminates NASH and Fibrosis in a Clinically Relevant Disease ... - Business Wire (press release) | Genfit | Scoop.it
GENFIT DEMONSTRATES THAT GFT505 ELIMINATES NASH AND FIBROSIS IN A CLINICALLY RELEVANT DISEASE MODEL.
more...
No comment yet.
Rescooped by leportos from PARP Inhibitors Cancer Review
Scoop.it!

Biotech Stock Mailbag: Next Biotech Takeout Targets, NewLink Genetics

Biotech Stock Mailbag: Next Biotech Takeout Targets, NewLink Genetics | Genfit | Scoop.it
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Via Krishan Maggon
more...
No comment yet.
Scooped by leportos
Scoop.it!

Breakthrough in fibrosis research - Medical Xpress

Breakthrough in fibrosis research - Medical Xpress | Genfit | Scoop.it
Researchers from the Departments of Pharmacy & Pharmacology and Biology & Biochemistry have made an important discovery that might lead to novel therapies to combat chronic fibrotic diseases.
more...
No comment yet.
Scooped by leportos
Scoop.it!

How PPAR delta receptor is resulting in the burning of fat

The PPAR-delta receptor activates certain genes in a muscle cell, resulting in the burning of fat. PPAR-delta is one of a family of receptors that is related...
more...
No comment yet.
Scooped by leportos
Scoop.it!

France's Genfit Said to Mull Sale Amid Health-Care Deal Boom - Bloomberg

France's Genfit Said to Mull Sale Amid Health-Care Deal Boom Bloomberg (Bloomberg) -- Genfit, a French drug developer, is exploring a sale of the business to capitalize on a surge of interest in medicines to treat a form of liver disease that's...
more...
No comment yet.
Rescooped by leportos from Pharma Biotech Industry Review (Krishan Maggon)
Scoop.it!

Takeda enlists GE's aid to tackle liver fibrosis epidemic - PMLiVE

Takeda enlists GE's aid to tackle liver fibrosis epidemic - PMLiVE | Genfit | Scoop.it

Takeda enlists GE's aid to tackle liver fibrosis epidemic
PMLiVE

 

Takeda is playing catch-up in the liver fibrosis race, with rivals such as Gilead Sciences, Intercept Pharmaceuticals, Galectin Therapeutics and Genfit already having compounds in the clinic.

Gilead's simtuzumab is in phase II testing in NASH, while Intercept's obeticholic acid candidate has just cleared a phase II trial and will enter phase III in 2015. France's Genfit has GFT505 in phase IIb trials for NASH while Galectin's GM-MD-02 for NAFLD is in phase I.

Meanwhile InterMune, which has been bought by Roche for $8bn, has said it has a pipeline of drugs with potential in liver and kidney fibrosis to go alongside Esbriet (pirfenidone), which is already approved to treat fibrosis in the lungs.


Via Krishan Maggon
more...
No comment yet.
Rescooped by leportos from Biotech, Pharmas and ideas
Scoop.it!

DIABÈTE de type 1 : Vers une insuline intelligente ? – PNAS

DIABÈTE de type 1 : Vers une insuline intelligente ?   – PNAS | Genfit | Scoop.it
Cette insuline intelligente contient un interrupteur moléculaire qui lui permet de répondre directement aux niveaux de glucose dans le sang et de mettre ainsi la glycémie sous contrôle.

Via Herve Ansanay
more...
No comment yet.
Scooped by leportos
Scoop.it!

ETC-1002 scores above 'PPAR' in phase IIb; for Esperion, PCSK9's bark worse ... - BioWorld Online

ETC-1002 scores above 'PPAR' in phase IIb; for Esperion, PCSK9's bark worse ... - BioWorld Online | Genfit | Scoop.it
By Randy Osborne Staff WriterInvestors hailed Esperion Therapeutics Inc.'s success with ETC-1002, the firm's dual-action cholesterol-lowering pill, sending upward the Ann Arbor, Mich.-based firm's st...
more...
No comment yet.
Scooped by leportos
Scoop.it!

Process of FEBICO Sorokina Formula Chlorella Sorokiniana PPAR Powder DETOX heavy metal

This is the top organic premium quality of microalgae Sorokina Formula Chlorella Sorokiniana PPAR powder produced by FEBICO Taiwan. It shows how effective it...
more...
No comment yet.